Related Experiment Video
Updated: Jan 29, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USA
Vicki A Morrison1, Yaping Shou2, Jill A Bell2
1Department of Medicine, University of Minnesota, Hennepin County Medical Center, Minneapolis, MN 55404, USA.
Aim:
To evaluate treatment patterns of diffuse large B-cell lymphoma (DLBCL).
Patients & Methods:
First-line and relapsed/refractory treatment patterns and survival outcomes following first-line therapy in adult patients newly diagnosed with DLBCL were evaluated.
Results:
A total of 1436 DLBCL patients initiated treatment and mainly received a combination regimen versus monotherapy (92.1 vs 7.9%). Patients who received monotherapy were older with more comorbidities and had shorter progression-free survival than patients receiving combination therapy (median: 31.3 vs 55.8 months). In the second-line setting (n = 164), rituximab-based combination regimens were most common; 25% underwent stem cell transplantation, and were younger with fewer comorbidities.
Conclusion:
These results illustrate the need for new treatment options for patients unable to tolerate initial combination therapy and transplant-ineligible patients who require salvage therapy.
More Related Videos
Related Concept Videos
Diffusion
Diffusion
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Comparing the Survival Analysis of Two or More Groups

